Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artemether-lumefantrine Vs Co-formulated Amodiaquine + Artesunate for the Treatment of Uncomplicated Falciparum Malaria: a Randomized Open-label Trial to Evaluate the Effectiveness of the Burkina Faso New Drug Policy

NCT01017770 is registered in ClinicalTrials.gov with Centre Muraz as lead sponsor.

NCT NCT01017770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01017770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artemether-lumefantrine Vs Co-formulated Amodiaquine + Artesunate for the Treatment of Uncomplicated Falciparum Malaria: a Randomized Open-label Trial to Evaluate the Effectiveness of the Burkina Faso New Drug Policy
Lead sponsor
Centre Muraz
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2008
Completion date
August 31, 2010
Enrollment
340 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated p. falciparum malaria in children